Both Maternal and Newborn IgMs Inhibit Transmissible Gastroenteritis Virus Internalization in LLC-PK1 Cells


  • A.P. Pogribna Institute of Molecular Biology and Genetics, NAS of Ukraine, 150 Akademika Zabolotnoho Str., Kyiv, 03143, Ukraine
  • B.E. Haran Kyiv Academic University, Department of Biomedicine and Neuroscience, 36 Akademika Vernadskoho Blvd, Kyiv, 03142, Ukraine
  • D.B. Starosyla Institute of Epidemiology and Infection Diseases, 5a Mykoly Amosova Str., Kyiv, 02000, Ukraine
  • S.L. Rybalko Institute of Epidemiology and Infection Diseases, 5a Mykoly Amosova Str., Kyiv, 02000, Ukraine
  • O.M. Deryabin Institute of Epidemiology and Infection Diseases, 5a Mykoly Amosova Str., Kyiv, 02000, Ukraine
  • V.V. Syvak Kyiv City Maternity Hospital No 5, 2 Valeriy Lobanovskyi Avenue, Kyiv, 03061, Ukraine
  • D.O. Govsieiev Bogomolets National Medical University, 13 Tarasa Shevchenka Blvd, Kyiv, 01601, Ukraine



Immunoglobulin M, cord blood serum, adult venous blood serum, epidermal growth factor receptor


Immunoglobulins M (IgMs) are the evolutionally oldest class of antibodies in higher eukaryotes. This pool of antibodies is one of the first to appear in humans and begins to be-synthesized at the early stages of the neonatal period. Most of the repertoire of IgMs of the newborns consists of the so-called «natural», or «naive», antibodies synthesized by the body without external antigenic stimulation. In addition to the classical functions of human immunoglobulins M (such as antigen recognition and initiation of innate immune responses), antibodies of this class exhibit a variety of non-canonical functions. The non-canonical functions are the action of antibodies as agonists/antagonists of various receptors, cleavage of antigen due to the catalytic activity of IgM, direct inactivation of pathogens in the absence of effector cells and molecules, etc. The aim of this work was to study and compare the antiviral activity of total preparations of immunoglobulin M of newborns and adults, obtained from umbilical cord and venous blood sera, on the LLC-PK1 cell line model infected with the transmissible gastroenteritis virus (TGEV). In addition, in the course of the studies, a decision was made to investigate the effect of combined preparations of immunoglobulin M on the change in signal transduction in the epidermal growth factor receptor as one of the mechanisms of TGEV internalization during infection of target cells. Methods. Highly purified preparations of total IgM of adults or newborns were obtained using the methodologies of sequential salt fractionation and affinity chromatography. This work used the model of the interaction of the transmissible gastroenteritis virus with cells of the LLC-PK1 line and the monitoring of changes in the phosphorylation state of the epidermal growth factor receptor of these cells during virus infection to study the effect of human IgM on the internalization of the virus and its interaction with the receptor system of the host cell. The degree of cytopathogenic effect of the virus was determined visually by changes in cell morphology. The mean infectious dose for transmissible gastroenteritis virus in the cell culture of the LLC-PK1 line was determined by the Reed-Muench method. Analysis of changes in the phosphorylation of the epidermal growth factor receptor was performed using the Western-blot analysis method. Results. The addition of a total high-purified sample of human IgM reduces the degree of efficiency of TGEV infection of the LLC-PK1 cell line and modulates the phosphorylation levels of these cells. Conclusions. The total preparations of IgM obtained from human venous blood of adults and from umbilical cord blood of newborns can affect the internalization of the transmissible gastroenteritis virus in the LLC-PK1 cell line. The original model of virus (TGEV) — cell line (LLC-PK1) was applied and tested to study the effect of native total preparations of immunoglobulin M on the internalization of the virus into the cell. The obtained data can be useful in further studies for a better understanding of the process of development and functioning of the immune system of newborns.


Download data is not yet available.


Mouthon L, Nobrega A, Nicolas N, Kaveri SV, Barreau C, Coutinho A, Kazatchkine MD. Invariance and restriction toward a limited set of self-antigens characterize neonatal IgM antibody repertoires and prevail in autoreactive repertoires of healthy adults. Proc Natl Acad Sci USA. 1995; 92(9):3839-43.

Boyden SV. Natural antibodies and the immune response. Adv Immunol. 1966; 5:1-28.

Casali P, Schettino EW. Structure and function of natural antibodies. Curr Top Microbiol Immunol. 1996; 210:167-79.

Bunker JJ, Erickson SA, Flynn TM, Henry C, Koval JC, Meisel M, Jabri B, Antonopoulos DA, Wilson PC, Bendelac A. Natural polyreactive IgA antibodies coat the intestinal microbiota. Science. 2017; 358(6361):eaan6619.

Lacroix-Desmazes S, Mouthon L, Kaveri SV, Kazatchkine MD, Weksler ME. Stability of natural self-reactive antibody repertoires during aging. J Clin Immunol. 1999; 19(1):26-34.

Hardy RR, Hayakawa K. CD5 B cells, a fetal B cell lineage. Adv Immunol. 1994; 55:297-339.

Avrameas S. Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton'. Immunol Today. 1991; 12(5):154-9.

Coutinho A, Kazatchkine MD, Avrameas S. Natural autoantibodies. Curr Opin Immunol. 1995; 7(6):812-8.

Haury M, Sundblad A, Grandien A, Barreau C, Coutinho A, Nobrega A. The repertoire of serum IgM in normal mice is largely independent of external antigenic contact. Eur J Immunol. 199; 27(6):1557-63.

Mouthon L, Haury M, Lacroix-Desmazes S, Barreau C, Coutinho A, Kazatchkine MD. Analysis of the normal human IgG antibody repertoire. Evidence that IgG autoantibodies of healthy adults recognize a limited and conserved set of protein antigens in homologous tissues. J Immunol. 1995; 154(11):5769-78.

Lacroix-Desmazes S, Mouthon L, Coutinho A, Kazatchkine MD. Analysis of the natural human IgG antibody repertoire: life-long stability of reactivities towards self antigens contrasts with age-dependent diversification of reactivities against bacterial antigens. Eur J Immunol. 1995; 25(9):2598-604.

Kantor AB, Herzenberg LA. Origin of murine B cell lineages. Annu Rev Immunol. 1993; 11:501-38.

Lalor PA, Herzenberg LA, Adams S, Stall AM. Feedback regulation of murine Ly-1 B cell development. Eur J Immunol. 1989; 19(3):507-13.

Düber S, Hafner M, Krey M, Lienenklaus S, Roy B, Hobeika E, Reth M, Buch T, Waisman A, Kretschmer K, Weiss S. Induction of B-cell development in adult mice reveals the ability of bone marrow to produce B-1a cells. Blood. 2009; 114(24):4960-7.

Holodick NE, Repetny K, Zhong X, Rothstein TL. Adult BM generates CD5+ B1 cells containing abundant N-region additions. Eur J Immunol. 2009; 39(9):2383-94.

Baumgarth N, Tung JW, Herzenberg LA. Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion. Springer Semin Immunopathol. 2005; 26(4):347-62.

Choi YS, Dieter JA, Rothaeusler K, Luo Z, Baumgarth N. B-1 cells in the bone marrow are a significant source of natural IgM. Eur J Immunol. 2012; 42(1):120-9.

Martin F, Oliver AM, Kearney JF. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity. 2001; 14(5):617-29.

Martin F, Kearney JF. Marginal-zone B cells. Nat Rev Immunol. 2002; 2(5):323-35.

Kretschmer K, Jungebloud A, Stopkowicz J, Kleinke T, Hoffmann R, Weiss S. The selection of marginal zone B cells differs from that of B-1a cells. J Immunol. 2003; 171(12):6495-501.

Carey JB, Moffatt-Blue CS, Watson LC, Gavin AL, Feeney AJ. Repertoire-based selection into the marginal zone compartment during B cell development. J Exp Med. 2008; 205(9):2043-52.

Dorshkind K, Montecino-Rodriguez E. Fetal B-cell lymphopoiesis and the emergence of B-1-cell potential. Nat Rev Immunol. 2007; 7(3):213-9.

Montecino-Rodriguez E, Leathers H, Dorshkind K. Identification of a B-1 B cell-specified progenitor. Nat Immunol. 2006; 7(3):293-301.

Boes M, Prodeus AP, Schmidt T, Carroll MC, Chen J. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med. 1998; 188(12):2381-6.

Ochsenbein AF, Fehr T, Lutz C, Suter M, Brombacher F, Hengartner H, Zinkernagel RM. Control of early viral and bacterial distribution and disease by natural antibodies. Science. 1999; 286(5447):2156-9.

Ochsenbein AF, Zinkernagel RM. Natural antibodies and complement link innate and acquired immunity. Immunol Today. 2000; 21(12):624-30.

Fellah JS, Wiles MV, Charlemagne J, Schwager J. Evolution of vertebrate IgM: complete amino acid sequence of the constant region of Ambystoma mexicanum mu chain deduced from cDNA sequence. Eur J Immunol. 1992; 22(10):2595-601.

Gonzalez-Quintela A, Alende R, Gude F, Campos J, Rey J, Meijide LM, Fernandez-Merino C, Vidal C. Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities. Clin Exp Immunol. 2008; 151(1):42-50.

Gong S, Ruprecht RM. Immunoglobulin M: An Ancient Antiviral Weapon - Rediscovered. Front Immunol. 2020; 11:1943.

Klimpel GR. Immune Defenses. In: Baron S, editor. Medical Microbiology. 4th edition. Galveston (TX): University of Texas Medical Branch at Galveston; 1996. Chapter 50. Available from:

Beerli C, Yakimovich A, Kilcher S, Reynoso GV, Fläschner G, Müller DJ, Hickman HD, Mercer J. Vaccinia virus hijacks EGFR signalling to enhance virus spread through rapid and directed infected cell motility. Nat Microbiol. 2019; 4(2):216-225.

Yarden Y. The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities. Eur J Cancer. 2001; 37 Suppl 4:S3-8.

Eierhoff T, Hrincius ER, Rescher U, Ludwig S, Ehrhardt C. The epidermal growth factor receptor (EGFR) promotes uptake of influenza A viruses (IAV) into host cells. PLoS Pathog. 2010; 6(9):e1001099.

Lupberger J, Zeisel MB, Xiao F, Thumann C, Fofana I, Zona L, Davis C, Mee CJ, Turek M, Gorke S, Royer C, Fischer B, Zahid MN, Lavillette D, Fresquet J, Cosset FL, Rothenberg SM, Pietschmann T, Patel AH, Pessaux P, Doffoël M, Raffelsberger W, Poch O, McKeating JA, Brino L, Baumert TF. EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nat Med. 2011; 17(5):589-95.

Ueki IF, Min-Oo G, Kalinowski A, Ballon-Landa E, Lanier LL, Nadel JA, Koff JL. Respiratory virus-induced EGFR activation suppresses IRF1-dependent interferon λ and antiviral defense in airway epithelium. J Exp Med. 2013; 210(10):1929-36.

Klann K, Bojkova D, Tascher G, Ciesek S, Münch C, Cinatl J. Growth Factor Receptor Signaling Inhibition Prevents SARS-CoV-2 Replication. Mol Cell. 2020; 80(1):164-174.e4.

Pleschka S, Wolff T, Ehrhardt C, Hobom G, Planz O, Rapp UR, Ludwig S. Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade. Nat Cell Biol. 2001; 3(3):301-5.

Venkataraman T, Frieman MB. The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis. Antiviral Res. 2017; 143:142-150.

Peiris JSM. Coronaviruses. Medical Microbiology. 2012:587-93.

López A, Martinson SA. Chapter 9 - Respiratory System, Mediastinum, and Pleurae1. Pathol Basis Vet Dis (Sixth Ed [Internet]. 2017; (2):471-560.e1.

Xiao W, Wang X, Wang J, Fang P, Xiao S, Fang L. Replicative capacity of four porcine enteric coronaviruses in LLC-PK1 cells. Arch Virol. 2021; 166(3):935-941.

Holbro T, Hynes NE. ErbB receptors: directing key signaling networks throughout life. Annu Rev Pharmacol Toxicol. 2004; 44:195-217.

Chen JK, Capdevila J, Harris RC. Heparin-binding EGF-like growth factor mediates the biological effects of P450 arachidonate epoxygenase metabolites in epithelial cells. Proc Natl Acad Sci USA. 2002; 99(9):6029-34.

Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5.

Zheng K, Kitazato K, Wang Y. Viruses exploit the function of epidermal growth factor receptor. Rev Med Virol. 2014; 24(4):274-86.

Iwamoto M, Saso W, Sugiyama R, Ishii K, Ohki M, Nagamori S, Suzuki R, Aizaki H, Ryo A, Yun JH, Park SY, Ohtani N, Muramatsu M, Iwami S, Tanaka Y, Sureau C, Wakita T, Watashi K. Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization. Proc Natl Acad Sci U S A. 2019; 116(17):8487-8492.

Iwamoto M, Saso W, Nishioka K, Ohashi H, Sugiyama R, Ryo A, Ohki M, Yun JH, Park SY, Ohshima T, Suzuki R, Aizaki H, Muramatsu M, Matano T, Iwami S, Sureau C, Wakita T, Watashi K. The machinery for endocytosis of epidermal growth factor receptor coordinates the transport of incoming hepatitis B virus to the endosomal network. J Biol Chem. 2020; 295(3):800-807.

Yang L, Xu J, Guo L, Guo T, Zhang L, Feng L, Chen H, Wang Y. Porcine Epidemic Diarrhea Virus-Induced Epidermal Growth Factor Receptor Activation Impairs the Antiviral Activity of Type I Interferon. J Virol. 2018; 92(8):e02095-17.

Hu W, Zhang S, Shen Y, Yang Q. Epidermal growth factor receptor is a co-factor for transmissible gastroenteritis virus entry. Virology. 2018; 521:33-43.

Qian S, Gao Z, Cao R, Yang K, Cui Y, Li S, Meng X, He Q, Li Z. Transmissible Gastroenteritis Virus Infection Up-Regulates FcRn Expression via Nucleocapsid Protein and Secretion of TGF-β in Porcine Intestinal Epithelial Cells. Front Microbiol. 2020; 10:3085.

Hu W, Zhu L, Yang X, Lin J, Yang Q. The epidermal growth factor receptor regulates cofilin activity and promotes transmissible gastroenteritis virus entry into intestinal epithelial cells. Oncotarget. 2016; 7(11):12206-21.




How to Cite

Pogribna, A., Haran, B., Starosyla, D., Rybalko, S., Deryabin, O., Syvak, V., & Govsieiev, D. (2023). Both Maternal and Newborn IgMs Inhibit Transmissible Gastroenteritis Virus Internalization in LLC-PK1 Cells. Mikrobiolohichnyi Zhurnal, 85(2), 60–74.